Alex Rodriguez Getty

Clinic records suggest Alex Rodriguez purchased HGH as recently as 2012; other players named

96 Comments

Over the weekend news broke that MLB and the Drug Enforcement Administration were investigating a clinic in Miami run by Anthony Bosch, a noted friend, adviser and consultant to many baseball players.  Bosch’s clinic has long been associated with so-called anti-aging therapies and he has long been associated with PEDs.  MLB reached out to the DEA because it does not have subpoena power and is interested in getting to the bottom of Bosch’s association with ballplayers.

Now a blockbuster report from the Miami New Times, which has been given patient records by an anonymous source, suggests that A-Rod and other ballplayers were, in fact, given HGH by Bosch. In A-Rod’s case as late as last year, long after he claimed that he had ceased using PEDs:

Yet there was his name, over and over again, logged as either “Alex Rodriguez,” “Alex Rod,” or his nickname at the clinic, “Cacique,” a pre-Columbian Caribbean chief. Rodriguez’s name appears 16 times throughout the records New Times reviewed.

Take, for instance, one patient list from Bosch’s 2009 personal notebook. It charts more than 50 clients and notes whether they received their drugs by delivery or in the office, how much they paid, and what they were taking.

There, at number seven on the list, is Alex Rodriguez. He paid $3,500, Bosch notes. Below that, he writes, “1.5/1.5 HGH (sports perf.) creams test., glut., MIC, supplement, sports perf. Diet.” HGH, of course, is banned in baseball, as are testosterone creams.

The New Times details multiple other records of banned substances, under either Rodriguez’s name or under his cousin Yuri Sucart. These include HGH, IGF-1, which stimulates muscle growth and is also banned and something called “troches,” which is a lozenge which releases testosterone.  But there is evidence of more recent use as well:

The mentions of Rodriguez begin in 2009 and continue all the way through last season. Take a page in another notebook, which is labeled “2012” and looks to have been written last spring. Under the heading “A-Rod/Cacique,” Bosch writes, “He is paid through April 30th. He will owe May 1 $4,000… I need to see him between April 13-19, deliver troches, pink cream, and… May meds. Has three weeks of Sub-Q (as of April).”

The New Times describes Sub-Q as a “mixture of HGH, IGF-1, and other drugs.”

Also mentioned in the records are Melky Cabrera, Yasmani Grandal and Bartolo Colon, all of whom have tested positive for PEDs in the past year.  One additional mention — a player never before linked with PEDs — is Nelson Cruz.  Gio Gonzalez is mentioned as well, but the records seem less definitive and may be connected to his father, who is quoted in the story.

The New Times attempted to get comment from all of the athletes named in the story. None responded.  Since the report was released, both Alex Rodriguez and Gio Gonzalez have issued statements.  Rodriguez’s statement, first reported by Joel Sherman of the New York Post:

“The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch’s patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story — at least as they relate to Alex Rodriguez — are not legitimate.”

Gonzalez’s statement:

“I’ve never used performance-enhancing drugs of any kind, and I never will. I’ve never met or spoken with Tony Bosch or used any substances provided by him. Anything said to the contrary is a lie.”

Major League Baseball has also issued a statement:

“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances.  These developments, however, provide evidence of the comprehensive nature of our anti-drug efforts.  Through our Department of Investigations, we have been actively involved in the issues in South Florida.  It is also important to note that three of the players allegedly involved have already been disciplined under the Joint Drug Program.

“The recommendations of the Mitchell Report have once again played a critical role in Major League Baseball’s ongoing efforts against performance-enhancing drugs.  MLB implemented all of the recommendations made by Senator Mitchell in 2007, several of which emphasized the significance of installing proactive investigative services.

“The establishment of our Department of Investigations has represented a critical advance in these comprehensive efforts.  In the years since its formation, DOI’s work has proven pivotal to bringing to light information regarding the use of performance-enhancing substances.  Furthermore, DOI has built strong working relationships with federal and local law enforcement authorities.  These relationships are crucial because only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs.

“Vigilance remains the key toward protecting the integrity of our game.  We have the best and most stringent drug testing policy in professional sports, we continue to work with our doctors and trainers to learn what they are seeing day-to-day and we educate our players about the game’s unbending zero-tolerance approach.  We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game.

“We are in the midst of an active investigation and are gathering and reviewing information.  We will refrain from further comment until this process is complete.”

This is a major, major story.  We have the east coast BALCO on our hands here.

Keep updating HardballTalk for the latest on this story and for our own unique analysis. Including Major League Baseball’s potential recourse against the named players and the likelihood that the Yankees could sue Alex Rodriguez to void his contract, which still has $114 million remaining.

Orioles are eying Welington Castillo as their primary catcher target

BALTIMORE, MD - SEPTEMBER 25: Welington Castillo #7 of the Arizona Diamondbacks warms up prior to taking an at bat against the Baltimore Orioles in the second inning at Oriole Park at Camden Yards on September 25, 2016 in Baltimore, Maryland. (Photo by Matt Hazlett/Getty Images)
Getty Images
Leave a comment

A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.

Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.

For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.

Report: Phillies agree to minor league deal with Daniel Nava

KANSAS CITY, MO - SEPTEMBER 12:  Daniel Nava #12 of the Kansas City Royals bats during the game against the Oakland Athletics at Kauffman Stadium on September 12, 2016 in Kansas City, Missouri.  (Photo by Jamie Squire/Getty Images)
Getty Images
2 Comments

The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.

Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.

Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.